Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Metabolic Positron Emission Tomography Response to Gamma Knife of the Ventral Intermediate Nucleus in Essential Tremor.

Verger A, Witjas T, Carron R, Eusebio A, Boutin E, Azulay JP, Regis J, Guedj E.

Neurosurgery. 2018 Jul 30. doi: 10.1093/neuros/nyy340. [Epub ahead of print]

PMID:
30085092
2.

Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy.

Lopez-Cuina M, Fernagut PO, Canron MH, Vital A, Lannes B, De Paula AM, Streichenberger N, Guehl D, Damier P, Eusebio A, Houeto JL, Tison F, Tranchant C, Viallet F, Witjas T, Thobois S, Meissner WG.

Neurobiol Dis. 2018 Oct;118:155-160. doi: 10.1016/j.nbd.2018.07.016. Epub 2018 Jul 17.

PMID:
30026036
3.

Beta burst coupling across the motor circuit in Parkinson's disease.

Tinkhauser G, Torrecillos F, Duclos Y, Tan H, Pogosyan A, Fischer P, Carron R, Welter ML, Karachi C, Vandenberghe W, Nuttin B, Witjas T, Régis J, Azulay JP, Eusebio A, Brown P.

Neurobiol Dis. 2018 Sep;117:217-225. doi: 10.1016/j.nbd.2018.06.007. Epub 2018 Jun 20.

4.

Brain PET substrate of impulse control disorders in Parkinson's disease: A metabolic connectivity study.

Verger A, Klesse E, Chawki MB, Witjas T, Azulay JP, Eusebio A, Guedj E.

Hum Brain Mapp. 2018 Aug;39(8):3178-3186. doi: 10.1002/hbm.24068. Epub 2018 Apr 10.

PMID:
29635851
5.

Subthalamic nucleus stimulation, dopaminergic treatment and impulsivity in Parkinson's disease.

Fluchère F, Burle B, Vidal F, van den Wildenberg W, Witjas T, Eusebio A, Azulay JP, Hasbroucq T.

Neuropsychologia. 2018 Aug;117:167-177. doi: 10.1016/j.neuropsychologia.2018.02.016. Epub 2018 Feb 16.

PMID:
29458074
6.

Limited Contribution of Primary Motor Cortex in Eye-Hand Coordination: A TMS Study.

Mathew J, Eusebio A, Danion F.

J Neurosci. 2017 Oct 4;37(40):9730-9740. doi: 10.1523/JNEUROSCI.0564-17.2017. Epub 2017 Sep 11.

7.

Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis.

Atkinson-Clement C, Pinto S, Eusebio A, Coulon O.

Neuroimage Clin. 2017 Jul 15;16:98-110. doi: 10.1016/j.nicl.2017.07.011. eCollection 2017. Review.

8.

Parkinson's disease associated with 22q11.2 deletion: Clinical characteristics and response to treatment.

Dufournet B, Nguyen K, Charles P, Grabli D, Jacquette A, Borg M, Danaila T, Mutez E, Drapier S, Colin O, Eusebio A, Philip N, Azulay JP.

Rev Neurol (Paris). 2017 Jun;173(6):406-410. doi: 10.1016/j.neurol.2017.03.021. Epub 2017 Apr 29.

9.

Treatment efficiency and economic feasibility of biological oxidation, membrane filtration and separation processes, and advanced oxidation for the purification and valorization of olive mill wastewater.

Ioannou-Ttofa L, Michael-Kordatou I, Fattas SC, Eusebio A, Ribeiro B, Rusan M, Amer AR, Zuraiqi S, Waismand M, Linder C, Wiesman Z, Gilron J, Fatta-Kassinos D.

Water Res. 2017 May 1;114:1-13. doi: 10.1016/j.watres.2017.02.020. Epub 2017 Feb 12.

PMID:
28214720
10.

[No motor signs in Parkinson's disease].

Azulay JP, Witjas T, Eusebio A.

Presse Med. 2017 Mar;46(2 Pt 1):195-201. doi: 10.1016/j.lpm.2016.11.015. Epub 2017 Jan 4. Review. French.

PMID:
28063757
11.

Essential tremor: Update of therapeutic strategies (medical treatment and gamma knife thalamotomy).

Witjas T, Carron R, Boutin E, Eusebio A, Azulay JP, Régis J.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):408-415. doi: 10.1016/j.neurol.2016.07.014. Epub 2016 Aug 22. Review.

PMID:
27561439
12.

Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations.

Eusebio A, Koric L, Félician O, Guedj E, Ceccaldi M, Azulay JP.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):488-502. doi: 10.1016/j.neurol.2016.07.009. Epub 2016 Aug 22. Review.

PMID:
27561438
13.

The human subthalamic nucleus encodes the subjective value of reward and the cost of effort during decision-making.

Zénon A, Duclos Y, Carron R, Witjas T, Baunez C, Régis J, Azulay JP, Brown P, Eusebio A.

Brain. 2016 Jun;139(Pt 6):1830-43. doi: 10.1093/brain/aww075. Epub 2016 Apr 27.

14.

Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort study.

Drapier S, Eusebio A, Degos B, Vérin M, Durif F, Azulay JP, Viallet F, Rouaud T, Moreau C, Defebvre L, Fraix V, Tranchant C, Andre K, Courbon CB, Roze E, Devos D.

J Neurol. 2016 Jun;263(6):1111-9. doi: 10.1007/s00415-016-8106-3. Epub 2016 Apr 8.

PMID:
27060084
15.

A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients.

Simon N, Viallet F, Boulamery A, Eusebio A, Gayraud D, Azulay JP.

Eur J Clin Pharmacol. 2016 Apr;72(4):423-30. doi: 10.1007/s00228-016-2034-0. Epub 2016 Mar 3.

PMID:
26936272
16.

Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia.

Pouclet-Courtemanche H, Rouaud T, Thobois S, Nguyen JM, Brefel-Courbon C, Chereau I, Cuny E, Derost P, Eusebio A, Guehl D, Laurencin C, Mertens P, Ory-Magne F, Raoul S, Regis J, Ulla M, Witjas T, Burbaud P, Rascol O, Damier P.

Neurology. 2016 Feb 16;86(7):651-9. doi: 10.1212/WNL.0000000000002370. Epub 2016 Jan 20.

PMID:
26791148
17.

Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature.

Meissner WG, Laurencin C, Tranchant C, Witjas T, Viallet F, Guehl D, Damier P, Houeto JL, Tison F, Eusebio A, Vital A, Streichenberger N, Lannes B, Maues de Paula A, Thobois S.

Parkinsonism Relat Disord. 2016 Mar;24:69-75. doi: 10.1016/j.parkreldis.2016.01.005. Epub 2016 Jan 7. Review.

PMID:
26778473
18.

A prospective single-blind study of Gamma Knife thalamotomy for tremor.

Witjas T, Carron R, Krack P, Eusebio A, Vaugoyeau M, Hariz M, Azulay JP, Régis J.

Neurology. 2015 Nov 3;85(18):1562-8. doi: 10.1212/WNL.0000000000002087. Epub 2015 Oct 7.

PMID:
26446066
19.

Delayed-onset Friedreich's ataxia revisited.

Lecocq C, Charles P, Azulay JP, Meissner W, Rai M, N'Guyen K, Péréon Y, Fabre N, Robin E, Courtois S, Guyant-Maréchal L, Zagnoli F, Rudolf G, Renaud M, Sévin-Allouet M, Lesne F, Alaerts N, Goizet C, Calvas P, Eusebio A, Guissart C, Derkinderen P, Tison F, Brice A, Koenig M, Pandolfo M, Tranchant C, Dürr A, Anheim M.

Mov Disord. 2016 Jan;31(1):62-9. doi: 10.1002/mds.26382. Epub 2015 Sep 21.

PMID:
26388117
20.

A preoperative metabolic marker of parkinsonian apathy following subthalamic nucleus stimulation.

Gesquière-Dando A, Guedj E, Loundou A, Carron R, Witjas T, Fluchère F, Delfini M, Mundler L, Regis J, Azulay JP, Eusebio A.

Mov Disord. 2015 Nov;30(13):1767-76. doi: 10.1002/mds.26349. Epub 2015 Jul 31.

PMID:
26228098
21.

News and controversies regarding essential tremor.

Boutin E, Vaugoyeau M, Eusebio A, Azulay JP, Witjas T.

Rev Neurol (Paris). 2015 May;171(5):415-25. doi: 10.1016/j.neurol.2015.02.007. Epub 2015 Apr 7. Review.

PMID:
25862370
22.

Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.

Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group.

Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23.

23.

Dopa therapy and action impulsivity: subthreshold error activation and suppression in Parkinson's disease.

Fluchère F, Deveaux M, Burle B, Vidal F, van den Wildenberg WP, Witjas T, Eusebio A, Azulay JP, Hasbroucq T.

Psychopharmacology (Berl). 2015 May;232(10):1735-46. doi: 10.1007/s00213-014-3805-x. Epub 2014 Dec 16.

PMID:
25510855
24.

Evaluation of a visual biofeedback on the postural control in Parkinson's disease.

Caudron S, Guerraz M, Eusebio A, Gros JP, Azulay JP, Vaugoyeau M.

Neurophysiol Clin. 2014 Jan;44(1):77-86. doi: 10.1016/j.neucli.2013.10.134. Epub 2013 Nov 5.

PMID:
24502908
25.

Controlled general anaesthesia for subthalamic nucleus stimulation in Parkinson's disease.

Fluchere F, Witjas T, Eusebio A, Bruder N, Giorgi R, Leveque M, Peragut JC, Azulay JP, Regis J.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1167-73. doi: 10.1136/jnnp-2013-305323. Epub 2013 Nov 18.

PMID:
24249783
26.

Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.

Devos D, Moreau C, Maltête D, Lefaucheur R, Kreisler A, Eusebio A, Defer G, Ouk T, Azulay JP, Krystkowiak P, Witjas T, Delliaux M, Destée A, Duhamel A, Bordet R, Defebvre L, Dujardin K.

J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):668-74. doi: 10.1136/jnnp-2013-306439. Epub 2013 Nov 11.

PMID:
24218528
27.

Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.

Eusebio A, Witjas T, Cohen J, Fluchère F, Jouve E, Régis J, Azulay JP.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):868-74. doi: 10.1136/jnnp-2012-302387. Epub 2013 Feb 27.

PMID:
23447648
28.

Effect of subthalamic deep brain stimulation on non-motor fluctuations in Parkinson's disease.

Azulay JP, Witjas T, Eusebio A.

J Neural Transm (Vienna). 2013 Apr;120(4):655-7. doi: 10.1007/s00702-012-0958-9. Epub 2012 Dec 23. Review.

PMID:
23263599
29.

Addictive behaviors and Parkinson's disease.

Witjas T, Eusebio A, Fluchère F, Azulay JP.

Rev Neurol (Paris). 2012 Aug-Sep;168(8-9):624-33. doi: 10.1016/j.neurol.2012.06.014. Epub 2012 Aug 24. Review.

PMID:
22921247
30.

Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects.

Eusebio A, Azulay JP, Ceccaldi M, Girard N, Mundler O, Guedj E.

Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1778-83. doi: 10.1007/s00259-012-2207-8. Epub 2012 Aug 14.

PMID:
22890804
31.

Movement-related changes in local and long-range synchronization in Parkinson's disease revealed by simultaneous magnetoencephalography and intracranial recordings.

Litvak V, Eusebio A, Jha A, Oostenveld R, Barnes G, Foltynie T, Limousin P, Zrinzo L, Hariz MI, Friston K, Brown P.

J Neurosci. 2012 Aug 1;32(31):10541-53. doi: 10.1523/JNEUROSCI.0767-12.2012.

32.

Does suppression of oscillatory synchronisation mediate some of the therapeutic effects of DBS in patients with Parkinson's disease?

Eusebio A, Cagnan H, Brown P.

Front Integr Neurosci. 2012 Jul 10;6:47. doi: 10.3389/fnint.2012.00047. eCollection 2012.

33.

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.

Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, Vuillaume I, Corvol JC, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Sablonniere B, Azulay JP, Tison F, Rascol O, Vidailhet M, Destée A, Bloem BR, Bordet R, Devos D; Parkgait-II study group.

Lancet Neurol. 2012 Jul;11(7):589-96. doi: 10.1016/S1474-4422(12)70106-0. Epub 2012 Jun 1. Erratum in: Lancet Neurol. 2012 Aug;11(8):658. Lancet Neurol. 2016 Mar;15(3):241. Lancet Neurol. 2016 Mar;15(3):241.

PMID:
22658702
34.

The Effectiveness of Motivational Interviewing on Glycemic Control for Adults with Type 2 Diabetes Mellitus (DM2): A Systematic Review.

Concert CM, Burke RE, Eusebio AM, Slavin EA, Shortridge-Baggett LM.

JBI Libr Syst Rev. 2012;10(42 Suppl):1-17.

PMID:
27820150
35.

A systematic review of the effectiveness of nurse coordinated transitioning of care on readmission rates for patients with heart failure.

Slyer JT, Concert CM, Eusebio AM, Rogers ME, Singleton J.

JBI Libr Syst Rev. 2011;9(15):464-490.

PMID:
27820542
36.

Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease.

Litvak V, Jha A, Eusebio A, Oostenveld R, Foltynie T, Limousin P, Zrinzo L, Hariz MI, Friston K, Brown P.

Brain. 2011 Feb;134(Pt 2):359-74. doi: 10.1093/brain/awq332. Epub 2010 Dec 8.

PMID:
21147836
37.

Molecular assessment of microbiota structure and dynamics along mixed olive oil and winery wastewaters biotreatment.

Eusébio A, Tacão M, Chaves S, Tenreiro R, Almeida-Vara E.

Biodegradation. 2011 Jul;22(4):773-95. doi: 10.1007/s10532-010-9434-0. Epub 2010 Nov 11.

PMID:
21069557
38.

Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients.

Eusebio A, Thevathasan W, Doyle Gaynor L, Pogosyan A, Bye E, Foltynie T, Zrinzo L, Ashkan K, Aziz T, Brown P.

J Neurol Neurosurg Psychiatry. 2011 May;82(5):569-73. doi: 10.1136/jnnp.2010.217489. Epub 2010 Oct 9.

39.

Excitability of the lower-limb area of the motor cortex in Parkinson's disease.

Vacherot F, Attarian S, Eusebio A, Azulay JP.

Neurophysiol Clin. 2010 Aug;40(4):201-8. doi: 10.1016/j.neucli.2010.04.002. Epub 2010 May 6.

PMID:
20674816
40.

Optimized beamforming for simultaneous MEG and intracranial local field potential recordings in deep brain stimulation patients.

Litvak V, Eusebio A, Jha A, Oostenveld R, Barnes GR, Penny WD, Zrinzo L, Hariz MI, Limousin P, Friston KJ, Brown P.

Neuroimage. 2010 May 1;50(4):1578-88. doi: 10.1016/j.neuroimage.2009.12.115. Epub 2010 Jan 4.

41.

A systematic review of the effectiveness of nurse coordinated transitioning of care on readmission rates for patients with heart failure.

Slyer JT, Concert CM, Eusebio AM, Rogers ME, Singleton J.

JBI Libr Syst Rev. 2010;8(24 Suppl):1-10. No abstract available.

PMID:
27820330
42.

Boosting cortical activity at Beta-band frequencies slows movement in humans.

Pogosyan A, Gaynor LD, Eusebio A, Brown P.

Curr Biol. 2009 Oct 13;19(19):1637-41. doi: 10.1016/j.cub.2009.07.074. Epub 2009 Oct 1.

43.

Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons.

Dehorter N, Guigoni C, Lopez C, Hirsch J, Eusebio A, Ben-Ari Y, Hammond C.

J Neurosci. 2009 Jun 17;29(24):7776-87. doi: 10.1523/JNEUROSCI.1527-09.2009.

44.

Resonance in subthalamo-cortical circuits in Parkinson's disease.

Eusebio A, Pogosyan A, Wang S, Averbeck B, Gaynor LD, Cantiniaux S, Witjas T, Limousin P, Azulay JP, Brown P.

Brain. 2009 Aug;132(Pt 8):2139-50. doi: 10.1093/brain/awp079. Epub 2009 Apr 15. Erratum in: Brain. 2013 Dec;136(Pt 12):e264.

45.

Deep brain stimulation modulates effects of motivation in Parkinson's disease.

Sauleau P, Eusebio A, Vandenberghe W, Nuttin B, Brown P.

Neuroreport. 2009 Apr 22;20(6):622-6. doi: 10.1097/WNR.0b013e32832aa928.

PMID:
19319004
46.

Synchronisation in the beta frequency-band--the bad boy of parkinsonism or an innocent bystander?

Eusebio A, Brown P.

Exp Neurol. 2009 May;217(1):1-3. doi: 10.1016/j.expneurol.2009.02.003. Epub 2009 Feb 20.

47.

Involvement of the subthalamic nucleus in engagement with behaviourally relevant stimuli.

Sauleau P, Eusebio A, Thevathasan W, Yarrow K, Pogosyan A, Zrinzo L, Ashkan K, Aziz T, Vandenberghe W, Nuttin B, Brown P.

Eur J Neurosci. 2009 Mar;29(5):931-42. doi: 10.1111/j.1460-9568.2009.06635.x. Epub 2009 Feb 14.

48.

Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.

Micallef J, Rey M, Eusebio A, Audebert C, Rouby F, Jouve E, Tardieu S, Blin O.

Br J Clin Pharmacol. 2009 Mar;67(3):333-40. doi: 10.1111/j.1365-2125.2008.03310.x. Epub 2008 Sep 19.

49.

Motor evoked potentials in clinically isolated syndrome suggestive of multiple sclerosis.

Rico A, Audoin B, Franques J, Eusebio A, Reuter F, Malikova I, Ali Cherif A, Pouget J, Pelletier J, Attarian S.

Mult Scler. 2009 Mar;15(3):355-62. doi: 10.1177/1352458508099612. Epub 2009 Jan 19.

PMID:
19153175
50.

Oscillatory activity in the basal ganglia.

Eusebio A, Brown P.

Parkinsonism Relat Disord. 2007;13 Suppl 3:S434-6. doi: 10.1016/S1353-8020(08)70044-0. Review.

PMID:
18267278

Supplemental Content

Loading ...
Support Center